PHASE I/II CLINICAL TRIAL OF AN ACTIVATED WHOLE TUMOR CELL VACCINE FOLLOWED BY TRANSFER OF IMMUNE T CELLS IN PATIENTS WITH MANTLE CELL LYMPHOMA. (June 2017) - Frank, M.; Khodadoust, M.; Chu, M.; Kohrt, H.; Advani, R.; Alizadeh, A.; Reddy, S.; Maeda, L.; Gupta, N.; Laport, G.; Meyer, E.; Miklos, D.; et al.